Tizanidine Tablets/Capsules Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules/Tablets
Available Strengths: 2 mg and 4 mg
Reference Brands: Zanaflex (US)
Category:
Multiple sclerosis
Tizanidine is a muscle relaxant that acts on alpha-2 adrenergic receptors, reducing nerve signaling and muscle spasm activity. It effectively relieves spasticity, decreases muscle stiffness, and improves movement. Benefits include quick symptom relief, muscle relaxation, and enhanced mobility, supporting better quality of life for patients with neurological conditions.
Tizanidine tablets/capsules is available in Oral Capsules/Tablets
and strengths such as 2 mg and 4 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tizanidine tablets/capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tizanidine tablets/capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tizanidine tablets, marketed as Zanaflex, are approved in the US by the FDA and in the EU via EMA for relief of spasticity associated with neurological conditions. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and manufacturing data, while the EMA ensures regional safety and quality compliance.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing